Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Consider index investing for broad diversification and low costs after establishing risk tolerance and goals. This guide points to ideal moments.
13,296 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Nike stock has fallen significantly from its 52-week peak, even as the CEO buys shares. This guide explains what the ...
Apple pushes to a fresh all-time high as AI-enabled products and a robust services ecosystem drive growth. The move w...
A famous AI investor argues the economics of AI deployment could shift cash flow toward infrastructure vendors like N...
As the 2026 COLA rises to 2.8%, investors turn to steady income stocks that more than cover the gap. A trio of picks ...
A trio of forces is reshaping how families preserve wealth for heirs. Rising long-term care costs, tax-policy uncerta...
Richard Branson is pushing back on the idea that waking up at 5 a.m. guarantees success. He argues a sustainable rout...
An unusual trading day put Lucid Group in the spotlight after rumors swirled about bankruptcy or going private. Learn...
CoreWeave has dropped substantially from its 52-week peak, leaving investors debating whether the bounce is coming or...
The memory market is showing persistent strength, and SK Hynix sits at the center of the narrative. This article expl...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
Cross-border investing in Europe can be tricky because taxes are taken at the source. This guide explains how withhol...